# Response to Intermittent Pneumatic Compression Therapy in Head and Neck Cancer-Related Lymphedema

> **NCT02946021** · PHASE1,PHASE2 · COMPLETED · sponsor: **Tactile Medical** · enrollment: 11 (actual)

## Conditions studied

- Head and Neck Neoplasms
- Head and Neck Lymphedema
- Head and Neck Cancer

## Interventions

- **DEVICE:** Head and neck garments for pneumatic compression device
- **DRUG:** NIRFLI with ICG

## Key facts

- **NCT ID:** NCT02946021
- **Lead sponsor:** Tactile Medical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10
- **Primary completion:** 2018-02
- **Final completion:** 2018-02
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2019-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02946021

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02946021, "Response to Intermittent Pneumatic Compression Therapy in Head and Neck Cancer-Related Lymphedema". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT02946021. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*